An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy
This study has been completed.
Sponsor:
Spectrum Health Hospitals
Collaborator:
Deltex Medical, Inc.
Information provided by:
Spectrum Health Hospitals
ClinicalTrials.gov Identifier:
NCT00467922
First received: April 27, 2007
Last updated: October 20, 2009
Last verified: October 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to find out if guided fluid administration with the esophageal monitor is superior to standard fluid administration and whether use of the hetastarch or lactated ringers offers different benefits with respect to length of stay in the hospital after hand-assisted colorectal surgery.
| Condition | Intervention | Phase |
|---|---|---|
|
Crohn's Disease Ulcerative Colitis Rectal Cancer Colon Cancer Colon Polyps Rectal Polyps Diverticulitis |
Drug: Hextend Drug: Lactated Ringers |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment |
| Official Title: | A Randomized Prospective Double Blind Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy: Standard Care Versus Either Colloid and Crystalloid |
Resource links provided by NLM:
MedlinePlus related topics:
Cancer
Colonic Polyps
Crohn's Disease
Diverticulosis and Diverticulitis
Ulcerative Colitis
U.S. FDA Resources
Further study details as provided by Spectrum Health Hospitals:
Primary Outcome Measures:
- Determine the relative effects of a standard, colloid or crystalloid based strategy for hand-assisted laparoscopic colectomy surgery on decreasing length of stay [ Time Frame: 90 days ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- 1. Determine the effects of the three fluid management strategies on post-operative fluid requirements in colorectal surgery. on the incidence and severity of post-operative complications. on return of gastrointestinal function. [ Time Frame: 90 days ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 69 |
| Study Start Date: | May 2007 |
| Study Completion Date: | October 2009 |
| Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
Intervention Details:
-
Drug: Hextend
Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy: Standard Care versus Either Colloid and Crystalloid
Drug: Lactated Ringers
Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy: Standard Care versus Either Colloid and Crystalloid
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Diagnoses of Crohn's disease, ulcerative colitis, rectal or colon cancer, colon or rectal polyps and chronic or subacute diverticulitis
- Subjects who will undergo hand-assisted laparoscopic colectomy for benign or malignant pathology
Exclusion Criteria:
- Patients requiring stoma formation as part of the operative procedure
- Patients undergoing loop ileostomy or colostomy closure thru the stomal site
- Bowel obstruction, coagulopathy, significant renal or hepatic dysfunction (creatinine >1.6 or liver enzymes > 50% upper limit of normal values)
- Congestive heart failure, unstable angina, or valvular heart disease with New York Heart Classification >2
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00467922
Locations
| United States, Michigan | |
| Spectrum Health | |
| Grand Rapids, Michigan, United States, 49503 | |
Sponsors and Collaborators
Spectrum Health Hospitals
Deltex Medical, Inc.
Investigators
| Principal Investigator: | Anthony Senagore, MD | Spectrum Health Hospitals |
More Information
No publications provided
| Responsible Party: | Dr. Anthony Senagore, Spectrum Health |
| ClinicalTrials.gov Identifier: | NCT00467922 History of Changes |
| Other Study ID Numbers: | 2007-109, 2007-109 |
| Study First Received: | April 27, 2007 |
| Last Updated: | October 20, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Spectrum Health Hospitals:
|
Hand-assisted colorectal surgery colorectal disease Crohn's diverticulitis Colorectal resections |
Additional relevant MeSH terms:
|
Colonic Neoplasms Rectal Neoplasms Colitis Colitis, Ulcerative Colonic Polyps Crohn Disease Diverticulitis Polyps Ulcer Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms |
Neoplasms by Site Neoplasms Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases Gastroenteritis Inflammatory Bowel Diseases Intestinal Polyps Pathological Conditions, Anatomical Pathologic Processes |
ClinicalTrials.gov processed this record on May 16, 2013